Lamotrigine combined with divalproex or lithium for bipolar disorder: A case series

CNS Spectrums

Volumn 11, Issue 12, 2006, Pages 915-918

  Redmond, James R ^a,d   Jamison, Katrina L ^b   Bowden, Charles L ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; LITHIUM; VALPROATE SEMISODIUM;

ADULT; AGED; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; CLINICAL GLOBAL IMPRESSION SCALE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OUTPATIENT; PILOT STUDY; PRIORITY JOURNAL; RASH; SCORING SYSTEM; SEDATION; SIDE EFFECT; SYMPTOM; TREMOR;

EID: 33845914054     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900015091     Document Type: Article

References (14)

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(suppl):1-50.
2. Bowden CL, Mitchell P, Suppes T. Lamotrigine in the treatment of bipolar depression. Eur Neuropsychopharmacol. 1999;9(suppl 4):S1113-S1117.
3. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry. 1999;60:79-88.
4. Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo controlled 18-month trials of lamotrigine and lithium maintenance in bipolar disorder. J Clin Psychiatry. 2004;65:432-441.
5. Calabrese JH, Suppes T, Bowden CL, et al. A double-blind placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000;61:841-850.
6. Bowden CL, Calabrese JR, McElroy SL, et al. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry. 1999;45:953-958.
7. Tohen M, Chengappa KM, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002;59:62-69.
8. Sachs GS, Grossman F, Ghaemi SN, Dkamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002;159:1146-1154.
9. Bowden CL. Making optimal use of combination pharmacotherapy in bipolar disorder. J Clin Psychiatry. 2004;65(suppl 15):21-24.
10. Worrall J, Moody J, Peet M, et al. Controlled studies of the acute antidepressant. effects of lithium. Br J Psychiatry. 1979;135:255-262.
11. Bowden CL, Collins MA, McElroy SL, et al. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium or placebo. Neuropsychopharmacology. 2005;30:1932-1939.
12. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry. 2000;57:481-489.
13. Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry. 2004;65:432-441.
14. Bowden C, Fawcett J. Pharmacotherapy and risk of suicidal behaviors among patients with bipolar disorder. JAMA. 2004;291:939.